Cullinan Oncology, Inc. (CGEM)
NASDAQ: CGEM · IEX Real-Time Price · USD
16.31
-0.42 (-2.51%)
At close: Jul 2, 2024, 4:00 PM
16.49
+0.18 (1.10%)
After-hours: Jul 2, 2024, 5:12 PM EDT
Cullinan Oncology Market Cap
Cullinan Oncology has a market cap or net worth of $940.01 million as of July 2, 2024. Its market cap has increased by 92.27% in one year.
Market Cap
940.01M
Enterprise Value
510.17M
1-Year Change
92.27%
Ranking
Category
Stock Price
$16.31
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Oncology's market cap has increased from $829.45M to $940.01M, an increase of 13.33%. That is a compound annual growth rate of 3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 964.20M | 121.20% |
| Dec 29, 2023 | 435.90M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.10M | -18.73% |
| Jan 8, 2021 | 829.45M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 1.03B |
| Innoviva | 1.02B |
| MiMedx Group | 1.02B |
| Gyre Therapeutics | 1.02B |
| Pharvaris | 1.01B |
| BioLife Solutions | 987.25M |
| Simulations Plus | 971.67M |
| Maravai LifeSciences Holdings | 951.07M |